A non-beta-lactam antibiotic inhibitor for enterohemorrhagic Escherichia coli O104:H4

被引：0
|
作者：
Haoqi Wang
Arul Jayaraman
Rani Menon
Varun Gejji
R. Karthikeyan
Sandun Fernando
机构：
[1] Texas A&M University,Department of Biological and Agricultural Engineering
[2] Texas A&M University,Department of Chemical Engineering
[3] Consulting Engineer,undefined
来源：
Journal of Molecular Medicine | 2019年 / 97卷
关键词：
Dynamic simulation; β-Lactamase; O104: H4; Non-β-lactam inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1285 / 1297
页数：12
相关论文
共 50 条
  • [41] Adaptive Mutations and Replacements of Virulence Traits in the Escherichia coli O104:H4 Outbreak Population
    Guy, Lionel
    Jernberg, Cecilia
    Norling, Jenny Arven
    Ivarsson, Sofie
    Hedenstrom, Ingela
    Melefors, Ojar
    Liljedahl, Ulrika
    Engstrand, Lars
    Andersson, Siv G. E.
    PLOS ONE, 2013, 8 (05):
  • [42] Shiga Toxin-Producing Escherichia coli O104:H4: a New Challenge for Microbiology
    Muniesa, Maite
    Hammerl, Jens A.
    Hertwig, Stefan
    Appel, Bernd
    Bruessow, Harald
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2012, 78 (12) : 4065 - 4073
  • [43] The Worst of Both Worlds: Examining the Hypervirulence of the Shigatoxigenic/Enteroaggregative Escherichia coli O104:H4
    Steiner, Theodore S.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (12): : 1860 - 1862
  • [44] Virulent Bacteriophages Can Target O104:H4 Enteroaggregative Escherichia coli in the Mouse Intestine
    Maura, Damien
    Galtier, Matthieu
    Le Bouguenec, Chantal
    Debarbieux, Laurent
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (12) : 6235 - 6242
  • [45] Lability of the pAA Virulence Plasmid in Escherichia coli O104:H4: Implications for Virulence in Humans
    Zhang, Wenlan
    Bielaszewska, Martina
    Kunsmann, Lisa
    Mellmann, Alexander
    Bauwens, Andreas
    Koeck, Robin
    Kossow, Annelene
    Anders, Agnes
    Gatermann, Soeren
    Karch, Helge
    PLOS ONE, 2013, 8 (06):
  • [46] Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab
    Delmas, Yahsou
    Vendrely, Benoit
    Clouzeau, Benjamin
    Bachir, Hiba
    Hoang-Nam Bui
    Lacraz, Adeline
    Helou, Sebastien
    Bordes, Cecile
    Reffet, Armel
    Llanas, Brigitte
    Skopinski, Sophie
    Rolland, Patrick
    Gruson, Didier
    Combe, Christian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (03) : 565 - 572
  • [47] Comparative virulence characterization of the Shiga toxin phage-cured Escherichia coli O104:H4 and enteroaggregative Escherichia coli
    Haarmann, Nadja
    Berger, Michael
    Kouzel, Ivan U.
    Mellmann, Alexander
    Berger, Petya
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 308 (07) : 912 - 920
  • [48] Epidemic Profile of Shiga-Toxin-Producing Escherichia coli O104:H4 Outbreak in Germany
    Frank, Christina
    Werber, Dirk
    Cramer, Jakob P.
    Askar, Mona
    Faber, Mirko
    an der Heiden, Matthias
    Bernard, Helen
    Fruth, Angelika
    Prager, Rita
    Spode, Anke
    Wadl, Maria
    Zoufaly, Alexander
    Jordan, Sabine
    Kemper, Markus J.
    Follin, Per
    Muller, Luise
    King, Lisa A.
    Rosner, Bettina
    Buchholz, Udo
    Stark, Klaus
    Krause, Gerard
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (19): : 1771 - 1780
  • [49] Serological Evidence of Asymptomatic Infections during Escherichia coli O104:H4 Outbreak in Germany in 2011
    Balabanova, Yanina
    Klar, Stefanie
    Delere, Yvonne
    Wilking, Hendrik
    Faber, Mirko S.
    Lassen, Sofie Gillesberg
    Gilsdorf, Andreas
    Dupke, Susann
    Nitschke, Martin
    Sayk, Friedhelm
    Grunow, Roland
    Krause, Gerard
    PLOS ONE, 2013, 8 (09):
  • [50] Entero-Aggregative-Haemorrhagic Escherichia coli (EAHEC) Serotype O104: H4 -The Evolving "Superbug"
    Biju, C. M.
    Befekadu, A. Y.
    Reji, S. D.
    Afework, K.
    Lan, W. C.
    John, J. B.
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2012, 11 (01): : 4 - +
12345